Status:

RECRUITING

Efficacy Of Oral Dexamethasone Versus Parenteral Dexamethasone In The Management Of Mild To Moderate Croup

Lead Sponsor:

Arooj Khan

Conditions:

Laryngotracheobronchitis

Croup

Eligibility:

All Genders

2-12 years

Phase:

NA

Brief Summary

Croup (laryngotracheobronchitis) is a viral infection of the upper airway that causes throat swelling, leading to a barking cough, stridor, and hoarseness. It mainly affects children aged 6 months to ...

Eligibility Criteria

Inclusion

  • Patient age 2 to 12 years
  • Both genders
  • Diagnosed with croup as operational definitions

Exclusion

  • Patients with chronic pulmonary disease like tuberculosis,
  • Allergy or contraindication of corticosteroid (history of tuberous sclerosis, history of varicella infection during the past three weeks), to corticosteroids,
  • history of corticosteroid administration during the last four weeks,
  • foreign body
  • patients with immunodeficiency disorder

Key Trial Info

Start Date :

June 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2025

Estimated Enrollment :

192 Patients enrolled

Trial Details

Trial ID

NCT06959407

Start Date

June 1 2024

End Date

July 1 2025

Last Update

May 21 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Khyber Teaching Hospital

Peshawar, KPK, Pakistan, 25000

Efficacy Of Oral Dexamethasone Versus Parenteral Dexamethasone In The Management Of Mild To Moderate Croup | DecenTrialz